Javascript must be enabled to continue!
Uncovering the underlying mechanism of cancer tumorigenesis and development under an immune microenvironment from global quantification of the landscape
View through CrossRef
The study of the cancer–immune system is important for understanding tumorigenesis and the development of cancer and immunotherapy. In this work, we build a comprehensive cancer–immune model including both cells and cytokines to uncover the underlying mechanism of cancer immunity based on landscape topography. We quantify three steady-state attractors, normal state, low cancer state and high cancer state, for the innate immunity and adaptive immunity of cancer. We also illustrate the cardinal inhibiting cancer immunity interactions and promoting cancer immunity interactions through global sensitivity analysis. We simulate tumorigenesis and the development of cancer and classify these into six stages. The characteristics of the six stages can be classified further into three groups. These correspond to the escape, elimination and equilibrium phases in immunoediting, respectively. Under specific cell–cell interactions strength oscillations emerge. We found that tumorigenesis and cancer recovery processes may need to go through cancer–immune oscillation, which consumes more energy. Based on the cancer–immune landscape, we predict three types of cells and two types of cytokines for cancer immunotherapy as well as combination immunotherapy. This landscape framework provides a quantitative way to understand the underlying mechanisms of the interplay between cancer and the immune system for cancer tumorigenesis and development.
Title: Uncovering the underlying mechanism of cancer tumorigenesis and development under an immune microenvironment from global quantification of the landscape
Description:
The study of the cancer–immune system is important for understanding tumorigenesis and the development of cancer and immunotherapy.
In this work, we build a comprehensive cancer–immune model including both cells and cytokines to uncover the underlying mechanism of cancer immunity based on landscape topography.
We quantify three steady-state attractors, normal state, low cancer state and high cancer state, for the innate immunity and adaptive immunity of cancer.
We also illustrate the cardinal inhibiting cancer immunity interactions and promoting cancer immunity interactions through global sensitivity analysis.
We simulate tumorigenesis and the development of cancer and classify these into six stages.
The characteristics of the six stages can be classified further into three groups.
These correspond to the escape, elimination and equilibrium phases in immunoediting, respectively.
Under specific cell–cell interactions strength oscillations emerge.
We found that tumorigenesis and cancer recovery processes may need to go through cancer–immune oscillation, which consumes more energy.
Based on the cancer–immune landscape, we predict three types of cells and two types of cytokines for cancer immunotherapy as well as combination immunotherapy.
This landscape framework provides a quantitative way to understand the underlying mechanisms of the interplay between cancer and the immune system for cancer tumorigenesis and development.
Related Results
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
EPD Electronic Pathogen Detection v1
EPD Electronic Pathogen Detection v1
Electronic pathogen detection (EPD) is a non - invasive, rapid, affordable, point- of- care test, for Covid 19 resulting from infection with SARS-CoV-2 virus. EPD scanning techno...
Profiling tumor immune microenvironment of non-small cell lung cancer using multiplex immunofluorescence
Profiling tumor immune microenvironment of non-small cell lung cancer using multiplex immunofluorescence
AbstractPurposeWe attempt to profile the tumor immune microenvironment (TIME) of non-small cell lung cancer (NSCLC) by multiplex immunofluorescence (MIF).Experimental DesignMIF tes...
Abstract 1270: ECHS1 mediates metabolic disruption in hormone receptor-positive breast tumor microenvironment
Abstract 1270: ECHS1 mediates metabolic disruption in hormone receptor-positive breast tumor microenvironment
Abstract
Unchecked hyperadiposity causes systemic metabolic perturbations and subclinical chronic inflammation, promoting hormone receptor positive (HR+) breast canc...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Abstract 283: Osteopontin cleavage fragments drive FGFR1-mediated mammary tumorigenesis
Abstract 283: Osteopontin cleavage fragments drive FGFR1-mediated mammary tumorigenesis
Abstract
Breast cancer is the second leading cause of cancer-related deaths in women in the United States. Over 40,000 women in the U.S. die of breast cancer annuall...
Abstract PL02-03: Immune modulation for cancer therapy: Assessing antagonists and agonists
Abstract PL02-03: Immune modulation for cancer therapy: Assessing antagonists and agonists
Abstract
The past decade has been a period of tremendous progress in the area of cancer immunotherapy. The field has progressed from a point where very modest subset...
Relationships of seven N6-methyladenosine regulators with the tumor microenvironment and tumor immune infiltrating cells
Relationships of seven N6-methyladenosine regulators with the tumor microenvironment and tumor immune infiltrating cells
Abstract
Background: N6-methyladenosine (m6A) modification plays key roles in tumor cell proliferation, invasion and immune escape, but the function of m6A modification in ...

